New recurrent UTI guideline: What urologists need to know
The AUA/CUA/SUFU guide focuses on a combination of symptoms and positive cultures.
Related Articles
Ilaha Isali, MD, and Laura Bukavina, MD, on the microbiome and bladder cancer
“I think integrating microbiome surveillance into clinical trials can bridge the gap between research and also therapeutic applications,” says Ilaha Isali, MD, MSc.
Bladder tumor-focused adaptive radiotherapy shows feasibility in phase 2 trial
“In this phase 2 study, an image-guided adaptive strategy enabled radiotherapy dose escalation to over 86% of patients’ bladder tumors without significant increase in toxicity,”…
Mark Edney, MD, on 3 key principles that improve job satisfaction
“What creates job satisfaction are 3 principles: mastery, autonomy, and a sense of purpose,” says Mark T. Edney, MD.
FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux
In a recent study of the RELIEF stent, 95% of patients showed no VUR following stent placement.
Fed Ghali, MD, on clinical outcomes in plasmacytoid urothelial carcinoma
“It’s hard for us, based on our evidence here, to say that neoadjuvant chemotherapy is causal in any way or is resulting in prolonged survival,”…
Jeffrey A. Albaugh, PhD, APRN, CUCNS, on editing the second edition of SUNA’s Core Curriculum
“It was a daunting task, although I will say the original core was exceptional, so I had a wonderful framework from which to work,” says…
FDA accepts NDA for 3-month leuprolide mesylate formulation for advanced prostate cancer
The PDUFA target action date has been set for August 29, 2025.
Enrollment goal met in trial of Urocross Expander Implant for BPH-related LUTS
The Expander-2 trial is intended to provide data that will support submission of the device for regulatory approval.
Amy Pearlman, MD, and Gia Ching on building a personal brand in urology
“I think the first thing you need to identify is, do you have a following, or do you have a niche that you know that…
The economics of bladder cancer in the US: Increasing costs and unsustainable patterns
“The increasing expenses associated with bladder cancer treatment highlight wider issues regarding the sustainability of health care expenditures in the US,” writes Michael S. Cookson,…